Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Half Year Ending September 2023 and Fiscal Year Ending March 2024
May 12, 2023 at 05:00 am
Share
Toho Holdings Co., Ltd. provided consolidated earnings guidance for the half year ending September 2023 and fiscal year ending March 2024. For the half year, Company expects net sales of JPY 651,000 million, operating profit of JPY 3,800 million, profit attributable to owners of parent JPY 6,700 million and basic earnings per share of JPY 100.05.
For the fiscal year end, Company expects net sales of JPY 1,325,000 million, operating profit of JPY 11,500 million, profit attributable to owners of parent JPY 12,300 million and basic earnings per share of JPY 183.67.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
